The apparent plateau comes as Johnson & Johnson prepares to begin distributing its one-shot vaccine following emergency use approval from the Food and Drug Administration. The company will initially supply a limited number of doses, after which it will ramp up production. The hope is that the more flexible vaccine will be easier to deploy in harder-to-reach areas.
More at WAPO